ArticleCancer science2017

Targeting of tumor growth and angiogenesis underlies the enhanced antitumor activity of lenvatinib in combination with everolimus.

Masahiro Matsuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.